Tag Archives: eight

CIVIS Media Prize 2022 | eight programmes honoured – documentary receives TOP AWARD

03.06.2022 – Cologne (ots) | The winners of the European CIVIS Media Prize for Integration and Cultural Diversity 2022 have been announced: The main prize of 15,000 euros, the CIVIS TOP AWARD, goes to the documentary film Schwarze Adler (Black Eagles) (Amazon Prime Video | BROADVIEW | ZDF), by author and director Torsten Körner. The… Read More: CIVIS Media Prize 2022 | eight programmes honoured – documentary… »

#FierceMadness pharma ad contest narrows: Pfizer, Bayer, Novartis, ViiV and Biohaven among the Elite Eight still standing

FierceMadess voters have spoken—and now, just an Elite Eight pharma advertisers are still in the running for the 2021 title.  Pfizer, Bayer, Novartis, Roche, Johnson & Johnson and GlaxoSmithKline’s ViiV Healthcare are among the Big Pharma contenders still playing in the DTC ad campaign contest, while Evofem Biosciences and Biohaven Pharmaceuticals are the smaller upstarts looking for… Read More: #FierceMadness pharma ad contest narrows: Pfizer, Bayer, Novartis, ViiV and… »

5 Amazing Impacts of Eight Hours Sleep on Our Body

The younger generation of the 21st century is career-oriented. They are ready to compromise with their health for their career. However, research suggests that sleep deprivation may lead to multiple diseases. A healthy individual needs seven to eight hours of sleep daily. While a person sleeps, the human body sends several signals to the brain… Read More: 5 Amazing Impacts of Eight Hours Sleep on Our Body »

Alzheimer’s disease: Eight risk factors for developing the disease – are you at risk?

Alzheimer’s disease is a form of dementia. Dementia refers to a set of symptoms, including problems with thinking, reasoning, learning, memory and language. Alzheimer’s is more likely as a person gets older. About one in every 100 people aged 65 have Alzheimer’s and this will rise to 40 out of every 100 by age 85.… Read More: Alzheimer’s disease: Eight risk factors for developing the disease –… »